News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

DiaGenic ASA: Notice of Allowance of United States Family 3 Breast Cancer Patent


10/6/2011 10:18:48 AM

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: DiaGenic (OSE:DIAG) has now received notice of allowance of the United States family 3 patent application (11/628,300). The claims allowed cover the use of some important gene sequences or the related proteins in blood sample for detection and monitoring of breast cancer in the US. The patent will be valid until 2025.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES